Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.94
- Piotroski Score 4.00
- Grade Hold
- Symbol (ONCO)
- Company Onconetix, Inc.
- Price $1.09
- Changes Percentage (-3.54%)
- Change -$0.04
- Day Low $1.07
- Day High $1.20
- Year High $21.40
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/21/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-37,409,694
Income Statement
Quarterly
Annual
Latest News of ONCO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ford reassigns hundreds in Michigan as it adjusts Bronco production
Ford Motor Co. is adjusting Bronco SUV production at its Michigan Assembly Plant, reassigning 400 workers for inventory balance and preparing for 2025 model production. Workers are offered short-term ...
By Yahoo! Finance | 10 hours ago -
NFL flexes Thursday night game for first time, tabs Chargers and Broncos to play in Week 16
The NFL is using its new flexibility to improve prime-time matchups, including changing Thursday night games. The Los Angeles Chargers will gain more exposure, with other games being moved to accommod...
By USA Today | 17 hours ago -
NFL moves Broncos-Chargers in Week 16 for first 'Thursday Night Football' flex
For the first time, the NFL has flexed a game into "Thursday Night Football," moving the Broncos vs. Chargers matchup to Dec. 19. This is part of a rule change allowing flex scheduling between Weeks 1...
By The New York Times | 19 hours ago
